Gut flora may offer new therapeutic targets for the traditional Chinese medicine enteric dialysis

Expert Opinion on Therapeutic Targets

Volumn 15, Issue 10, 2011, Pages 1147-1152

  Shu, Zhan Jun ^a   Cao, Ying ^a   Halmurat, Upur ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Enteric dialysis; gut flora; new therapeutic targets; traditional Chinese medicine

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; PLANT EXTRACT; TARAXACUM MONGOLICUM EXTRACT; UNCLASSIFIED DRUG;

CHINESE MEDICINE; CHRONIC KIDNEY DISEASE; CREATININE CLEARANCE; DIALYSIS; DISEASE COURSE; FLORA; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INTESTINE; INTESTINE FLORA; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; PERITONEAL DIALYSIS; PREVALENCE; REVIEW; TRADITIONAL MEDICINE; UREA NITROGEN BLOOD LEVEL;

FERMENTATION; GLOMERULAR FILTRATION RATE; HUMANS; INTESTINES; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MEDICINE, CHINESE TRADITIONAL; PERITONEAL DIALYSIS;

EID: 80052902542     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2011.614234     Document Type: Review

References (45)

1. Friedman EA. Can the bowel substitute for the kidney in advanced renal failure? Curr Med Res Opin 2009;25(8):1913-18
2. Schepers E, Glorieux G, Vanholder R. The gut: the forgotten organ in uremia? Blood Purif 2010;29(2):130-6
3. Sparks RE. Review of gastrointestinal perfusion in the treatment of uremia. Clin Nephrol 1979;11(2):81-5 (Pubitemid 9128639)
4. Ranganathan N, Ranganathan P, Friedman EA, et al. Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease. Adv Ther 2010;27(9):634-47
5. Yokozawa T, Suzuki N, Okuda I, et al. Changes in the urinary constituents in rats with chronic renal failure during oral administration of rhubarb extract. Chem Pharm Bull (Tokyo) 1985;33(10):4508-14 (Pubitemid 16205699)
6. Young TK, Lee SC, Tang CK. Diarrhea therapy of uremia. Clin Nephrol 1979;11(2):86-91 (Pubitemid 9128640)
7. Young TK, Lee SC, Tai LN. Mannitol absorption and excretion in uremic patients regularly treated with gastrointestinal perfusion. Nephron 1980;25(3):112-16 (Pubitemid 10128729)
8. Walker JB, Hannan JK. Creatine biosynthesis during embryonic development. False feedback suppression of liver amidinotransferase by N- acetimidoylsarcosine and 1-carboxymethyl-2-iminoimidazolidine (cyclocreatine). Biochemistry 1976;15(12):2519-22
9. Oi H, Matsuura D, Miyake M, et al. Identification in traditional herbal medications and confirmation by synthesis of factors that inhibit cholera toxin-induced fluid accumulation. Proc Natl Acad Sci USA 2002;99(5):3042-6 (Pubitemid 34240582)
10. Li LS, Liu ZH. Clinical and experimental studies of rheum on preventing progression of chronic renal failure. Zhongguo Zhong Xi Yi Jie He Za Zhi 1991;11(7):392-6
11. Zheng JM, Zhu JM, Li LS, et al. Rhein reverses the diabetic phenotype of mesangial cells over-expressing the glucose transporter (GLUT1) by inhibiting the hexosamine pathway. Br J Pharmacol 2008;153(7):1456-64
12. Yang JW, Li LS. Effects of Rheum on renal hypertrophy and hyperfiltration of experimental diabetes in rat. Zhongguo Zhong Xi Yi Jie He Za Zhi 1993;13(5):286-8
13. Yokozawa T, Fujioka K, Oura H, et al. Effects of rhubarb tannins on uremic toxins. Nephron 1991;58(2):155-60
14. Zhang G, el Nahas AM. The effect of rhubarb extract on experimental renal fibrosis. Nephrol Dial Transplant 1996;11(1):186-90 (Pubitemid 26038487)
15. Jin YR, Jin J, Piao XX, et al. The effect of Taraxacum officinale on gastric emptying and smooth muscle motility in Rodents. Neurogastroenterol Motil 2011;23(8):766-e333
16. Koh YJ, Cha DS, Ko JS, et al. Anti-inflammatory effect of Taraxacum officinale leaves on lipopolysaccharide-induced inflammatory responses in RAW 264.7 cells. J Med Food 2010;13(4):870-8
17. Kim YH, Choo SJ, Ryoo IJ, et al. Eudesmanolides from Taraxacum mongolicum and their inhibitory effects on the production of nitric oxide. Arch Pharmacol Res 2011;34(1):37-41
18. Whitman WB, Coleman DC, Wiebe WJ. Prokaryotes: the unseen majority. Proc Natl Acad Sci USA 1998;95(12):6578-83 (Pubitemid 28278022)
19. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science 2005;308(10):1635-8 (Pubitemid 40807514)
20. McCartney AL. Application of molecular biological methods for studying probiotics and the gut flora. Br J Nutr 2002;88(Suppl 1):S29-37 (Pubitemid 35251941)
21. Gill SR, Pop M, Deboy RT, et al. Metagenomic analysis of the human distal gut microbiome. Science 2006;312(2):1355-9 (Pubitemid 43839542)
22. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003;361(5):512-19 (Pubitemid 36173720)
23. Scanlan PD, Marchesi JR. Micro-eukaryotic diversity of the human distal gut microbiota: qualitative assessment using culture-dependent and -independent analysis of faeces. ISME J 2008;2(12):1183-93
24. Breitbart M, Rohwer F. Here a virus, there a virus, everywhere the same virus? Trends Microbiol 2005;13(6):278-84 (Pubitemid 40779816)
25. Dethlefsen L, McFall-Ngai M, Relman DA. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 2007;449(10):811-18 (Pubitemid 47598621)
26. Collins MD, Gibson GR. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr 1999;69(5):1052S-7S
27. Macfarlane GT, Macfarlane S. Models for intestinal fermentation: association between food components, delivery systems, bioavailability and functional interactions in the gut. Curr Opin Biotechnol 2007;18(2):156-62 (Pubitemid 46584797)
28. Guarner F. Enteric flora in health and disease. Digestion 2006;73(Suppl 1):5-12
29. Jones JD, Burnett PC. Creatinine metabolism in humans with decreased renal function: creatinine deficit. Clin Chem 1974;20(9):1204-12
30. Mitch WE. Effects of intestinal flora on nitrogen metabolism in patients with chronic renal failure. Am J Clin Nutr 1978;31(9):1594-600 (Pubitemid 9034100)
31. Simenhoff ML, Saukkonen JJ, Burke JF, et al. Bacterial populations of the small intestine in uremia. Nephron 1978;22(1-3):63-8 (Pubitemid 9051804)
32. Levanova LA, Aleshkin VA, Vorob'ev AA, et al. Specific biological features of opportunistic bacteria determining dysbacteriosis in the composition of the large intestine normal microflora. Zh Mikrobiol Epidemiol Immunobiol 2002;Sep-Oct(5):48-53
33. Hida M, Aiba Y, Sawamura S, et al. Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis. Nephron 1996;74(2):349-55 (Pubitemid 26326708)
34. Gu KF, Chang TM. Conversion of ammonia or urea into essential amino acids, L-leucine, L-valine, and L-isoleucine, using artificial cells containing an immobilized multienzymesystem and dextran-NAD+. 2. Yeast alcohol dehydrogenase for coenzyme recycling. Biotechnol Appl Biochem 1990;12(3):227-36 (Pubitemid 20305154)
35. Chow KM, Liu ZC, Prakash S,Chang TM. Free and microencapsulated Lactobacillus and effects of metabolic induction on urea removal. Artif Cells Blood Substit Immobil Biotechnol 2003;31(4):425-34 (Pubitemid 37474288)
36. O'Loughlin JA, Bruder JM, Lysaght MJ. Degradation of low molecular weight uremic solutes by oral delivery of encapsulated enzymes. Asaio J 2004;50(3):253-60 (Pubitemid 38608112)
37. Prakash S, Chang TM. Artificial cells microencapsulated genetically engineered E. coli DH5 cells for the lowering of plasma creatinine in-vitro and in-vivo. Artif Cells Blood Substit Immobil Biotechnol 2000;28(5):397-408
38. Ranganathan N, Friedman EA, Tam P, et al. Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada. Curr Med Res Opin 2009;25(8):1919-30
39. Ranganathan N, Patel BG, Ranganathan P, et al. In vitro and in vivo assessment of intraintestinal bacteriotherapy in chronic kidney disease. Asaio J 2006;52(1):70-9 (Pubitemid 44314900)
40. Turnbaugh PJ, Ley RE, Hamady M, et al. The human microbiome project. Nature 2007;449(10):804-10 (Pubitemid 47598620)
41. Ahmed N. A flood of microbial genomes-do we need more? PLoS One 2009;4(6):e5831
42. Eisen JA. Environmental shotgun sequencing: its potential and challenges for studying the hidden world of microbes. PLoS Biol 2007;5(3):e82
43. Hattori M, Taylor TD. The human intestinal microbiome: a new frontier of human biology. DNA Res 2009;16(1):1-12
44. Hattori M. Disease and metagenomics of intestinal microbiomes. Nippon Rinsho 2009;67(6):1214-18
45. Aziz RK. A hundred-year-old insight into the gut microbiome!. Gut Pathog 2009;1(1):21